Review summary
Historical dates
February 26, 1932 – September 12, 2003Synthetic DOB
1932-02-26Index visit
2003-02-27 at age 71Synthetic MRN
HR-ML004-SYN-TDTeaching objective: Recognize that orthostatic lightheadedness, leg numbness, and falls in an older adult with long-standing type 2 diabetes fit diabetic autonomic and peripheral neuropathy rather than a prior label of Shy-Drager syndrome; set an individualized HbA1c goal, choose glucose-lowering drugs that avoid hypoglycemia, treat neurogenic orthostatic hypotension, and coordinate glaucoma care so that eye drops do not worsen blood pressure, using the CMID diabetes and glaucoma schedules.
Historical timeline
| Date | Event | Claims |
|---|---|---|
| February 26, 1932 | Born in Kingsland, Arkansas. | CLM-0001 |
| 1944 | Older brother Jack died in a sawmill accident. | CLM-0003 |
| 1957 | Began taking amphetamines on the road; addiction lasted about a decade. | CLM-0004 |
| 1983 | Hospitalized with internal bleeding; then treated at the Betty Ford Clinic. | CLM-0005 |
| October 1997 | Diagnosed with Shy-Drager syndrome, later called a misdiagnosis. | CLM-0006 |
| February 2001 | Treated for pneumonia at Baptist Hospital in Nashville. | CLM-0008 |
| November 26, 2002 | Described autonomic neuropathy, diabetes, glaucoma, and loss of about 60 percent of his vision in a televised interview. | CLM-0007, CLM-0008, CLM-0009 |
| September 12, 2003 | Died at Baptist Hospital in Nashville of complications of diabetes with respiratory failure. | CLM-0002 |
Evidence claims
D = documented, R = retrospective, S = synthetic.
| Grade | Claim | Certainty | Sources |
|---|---|---|---|
| D | J. R. (Johnny) Cash was born on February 26, 1932, in Kingsland, Cleveland County, Arkansas, to Ray and Carrie Cash. | confirmed | Johnny Cash (1932-2003) supports |
| D | Cash died at Baptist Hospital in Nashville, Tennessee, on September 12, 2003; his manager, Lou Robin, said in a statement issued by the hospital that he died of complications from diabetes, which resulted in respiratory failure. Public statement by his manager; the documented basis for the diabetes in this case. Record the death without graphic detail. |
confirmed | Johnny Cash (1932-2003) supports Johnny Cash Dies supports |
| D | Cash's older brother Jack died in a sawmill accident in 1944. Family event; an injury, not a heritable condition. |
confirmed | Johnny Cash (1932-2003) supports |
| D | In 1957 Cash began taking amphetamines to stay awake on a long road trip, the start of an addiction that lasted about a decade; in a 2002 interview he named amphetamines and barbiturates in the 1960s. Historical substance use made public by Cash and his biographers. It is not a modern diagnosis in this case. |
confirmed | Johnny Cash (1932-2003) supports Larry King Live: Interview With Johnny Cash (transcript) supports |
| D | Cash was hospitalized in 1983 with internal bleeding; after recovering he entered the Betty Ford Clinic for treatment. Historical treatment for substance use; the cited encyclopedia states he remained abstinent afterward. |
confirmed | Johnny Cash (1932-2003) supports |
| D | In October 1997 Cash was diagnosed with Shy-Drager syndrome, an illness similar to Parkinson's disease; in a 2000 interview he said the diagnosis was a misdiagnosis. The diagnosis and its withdrawal were both made public by Cash. The case uses the withdrawn label as a teaching point about autonomic failure in diabetes. |
confirmed | Johnny Cash Battles Recurring Pneumonia supports Larry King Live: Interview With Johnny Cash (transcript) context |
| D | Cash later learned he had autonomic neuropathy; in November 2002 he described it as a deadening of the nerve endings in his lower extremities that had taken the strength from his legs, so that he could walk, but not very well. Self-reported diagnosis; the anchor for the synthetic diabetic autonomic and peripheral neuropathy. |
confirmed | Johnny Cash (1932-2003) supports Larry King Live: Interview With Johnny Cash (transcript) supports Johnny Cash Dies supports |
| D | Cash was repeatedly hospitalized for pneumonia in his last years; he was treated for pneumonia at Baptist Hospital in Nashville in February 2001, and in November 2002 he said he had had pneumonia four times in three years. | confirmed | Johnny Cash (1932-2003) supports Johnny Cash Battles Recurring Pneumonia supports Larry King Live: Interview With Johnny Cash (transcript) supports |
| D | In November 2002 Cash said about 60 percent of his vision was gone, which he attributed to the neuropathy and the diabetes, and he said he hoped the glaucoma could also be reversed. His own lay account; the type and stage of glaucoma and any retinal findings were not made public. |
probable | Larry King Live: Interview With Johnny Cash (transcript) supports |
Modern synthetic problem list
| Grade | Problem | Clinical status | Verification | Placement | Historical claims |
|---|---|---|---|---|---|
| S | Type 2 diabetes mellitus with diabetic autonomic neuropathy; HbA1c above the individualized goal at intake | active | confirmed | both_with_link | CLM-0002, CLM-0007 |
| S | Neurogenic orthostatic hypotension from diabetic autonomic neuropathy | active | confirmed | both_with_link | CLM-0006, CLM-0007 |
| S | Diabetic distal symmetric polyneuropathy with loss of protective sensation in both feet | active | confirmed | both_with_link | CLM-0007 |
| S | Primary open-angle glaucoma, both eyes, severe stage | active | confirmed | both_with_link | CLM-0009 |
| S | Mild nonproliferative diabetic retinopathy without macular edema, both eyes | active | confirmed | active | |
| S | Hyperlipidemia | active | confirmed | active | |
| S | History of recurrent pneumonia | active | confirmed | both_with_link | CLM-0008 |
Synthetic outcome measures
| Grade | Date | Measure | Result | Coding |
|---|---|---|---|---|
| S | 2003-02-27 | Hemoglobin A1c/Hemoglobin.total in Blood | 8.6% (high) Reference <=5.6% |
http://loinc.org · 4548-4 |
| S | 2003-02-27 | Sodium [Moles/volume] in Serum or Plasma | 138 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 2003-02-27 | Potassium [Moles/volume] in Serum or Plasma | 4.4 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 2003-02-27 | Creatinine [Mass/volume] in Serum or Plasma | 1.04 mg/dL Reference 0.74-1.35 mg/dL |
http://loinc.org · 2160-0 |
| S | 2003-02-27 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1998)/1.73 sq M | 74 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 2003-02-27 | Glucose [Mass/volume] in Serum or Plasma | 186 mg/dL (high) Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 2003-02-27 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 128 mg/dL (high) Reference <=99 mg/dL |
http://loinc.org · 13457-7 |
| S | 2003-02-27 | Albumin/Creatinine [Mass Ratio] in Urine | 18 mg/g Reference <=30 mg/g |
http://loinc.org · 9318-7 |
| S | 2003-02-27 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 U/L Reference 7-56 U/L |
http://loinc.org · 1742-6 |
| S | 2003-02-27 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 22 U/L Reference 10-40 U/L |
http://loinc.org · 1920-8 |
| S | 2003-02-27 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 286 pg/mL Reference 232-1245 pg/mL |
http://loinc.org · 2132-9 |
| S | 2003-02-27 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 mIU/L Reference 0.45-4.5 mIU/L |
http://loinc.org · 3016-3 |
| S | 2003-02-27 | Hemoglobin [Mass/volume] in Blood | 13.8 g/dL Reference 13.2-16.6 g/dL |
http://loinc.org · 718-7 |
| S | 2003-02-27 | Right eye Intraocular pressure | 22 mmHg (high) Reference 10-21 mmHg |
http://loinc.org · 79892-6 |
| S | 2003-02-27 | Left eye Intraocular pressure | 24 mmHg (high) Reference 10-21 mmHg |
http://loinc.org · 79893-4 |
| S | 2003-02-27 | Right retina Retinal nerve fiber layer.mean thickness by OCT | 61 um (low) Reference 80-120 um |
http://loinc.org · 86301-9 |
| S | 2003-02-27 | Left retina Retinal nerve fiber layer.mean thickness by OCT | 57 um (low) Reference 80-120 um |
http://loinc.org · 86290-4 |
| S | 2003-02-27 | Visual acuity best corrected Right eye by ETDRS eye chart | 68 (low) Reference >=80 |
http://loinc.org · 79876-9 |
| S | 2003-02-27 | Visual acuity best corrected Left eye by ETDRS eye chart | 63 (low) Reference >=80 |
http://loinc.org · 79877-7 |
| S | 2003-02-27 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | http://loinc.org · 55758-7 |
| S | 2003-02-27 | Total score [Mini-Cog] | 5 | http://loinc.org · 72233-0 |
| S | 2003-03-27 | Sodium [Moles/volume] in Serum or Plasma | 139 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 2003-03-27 | Potassium [Moles/volume] in Serum or Plasma | 4.3 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 2003-03-27 | Creatinine [Mass/volume] in Serum or Plasma | 1.06 mg/dL Reference 0.74-1.35 mg/dL |
http://loinc.org · 2160-0 |
| S | 2003-03-27 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1998)/1.73 sq M | 72 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 2003-03-27 | Glucose [Mass/volume] in Serum or Plasma | 152 mg/dL (high) Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 2003-05-29 | Hemoglobin A1c/Hemoglobin.total in Blood | 7.7% (high) Reference <=5.6% |
http://loinc.org · 4548-4 |
| S | 2003-05-29 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 74 mg/dL Reference <=99 mg/dL |
http://loinc.org · 13457-7 |
| S | 2003-05-29 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 27 U/L Reference 7-56 U/L |
http://loinc.org · 1742-6 |
| S | 2003-05-29 | Right eye Intraocular pressure | 15 mmHg Reference 10-21 mmHg |
http://loinc.org · 79892-6 |
| S | 2003-05-29 | Left eye Intraocular pressure | 16 mmHg Reference 10-21 mmHg |
http://loinc.org · 79893-4 |
| S | 2003-05-29 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | http://loinc.org · 55758-7 |
| S | 2003-08-14 | Hemoglobin A1c/Hemoglobin.total in Blood | 7.3% (high) Reference <=5.6% |
http://loinc.org · 4548-4 |
| S | 2003-08-14 | Sodium [Moles/volume] in Serum or Plasma | 140 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 2003-08-14 | Potassium [Moles/volume] in Serum or Plasma | 4.5 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 2003-08-14 | Creatinine [Mass/volume] in Serum or Plasma | 1.05 mg/dL Reference 0.74-1.35 mg/dL |
http://loinc.org · 2160-0 |
| S | 2003-08-14 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1998)/1.73 sq M | 73 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 2003-08-14 | Glucose [Mass/volume] in Serum or Plasma | 131 mg/dL (high) Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 2003-08-14 | Albumin/Creatinine [Mass Ratio] in Urine | 16 mg/g Reference <=30 mg/g |
http://loinc.org · 9318-7 |
| S | 2003-08-14 | Right eye Intraocular pressure | 14 mmHg Reference 10-21 mmHg |
http://loinc.org · 79892-6 |
| S | 2003-08-14 | Left eye Intraocular pressure | 15 mmHg Reference 10-21 mmHg |
http://loinc.org · 79893-4 |
| S | 2003-08-14 | Right retina Retinal nerve fiber layer.mean thickness by OCT | 60 um (low) Reference 80-120 um |
http://loinc.org · 86301-9 |
| S | 2003-08-14 | Left retina Retinal nerve fiber layer.mean thickness by OCT | 57 um (low) Reference 80-120 um |
http://loinc.org · 86290-4 |
| S | 2003-08-14 | Visual acuity best corrected Right eye by ETDRS eye chart | 68 (low) Reference >=80 |
http://loinc.org · 79876-9 |
| S | 2003-08-14 | Visual acuity best corrected Left eye by ETDRS eye chart | 62 (low) Reference >=80 |
http://loinc.org · 79877-7 |
| S | 2003-04-24 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | http://loinc.org · 55758-7 |
| S | 2003-04-24 | Total score [AUDIT-C] | 0 | http://loinc.org · 75626-2 |
Synthetic vital signs
| Date | Measure | Result | LOINC | Grade |
|---|---|---|---|---|
| 2003-02-27 | Body height | 188 cm | 8302-2 | S |
| 2003-02-27 | Body weight | 96 kg | 29463-7 | S |
| 2003-02-27 | Body mass index (BMI) [Ratio] | 27.2 kg/m2 | 39156-5 | S |
| 2003-02-27 | Systolic blood pressure | 146 mm[Hg] | 8480-6 | S |
| 2003-02-27 | Diastolic blood pressure | 80 mm[Hg] | 8462-4 | S |
| 2003-02-27 | Heart rate | 78 /min | 8867-4 | S |
| 2003-02-27 | Respiratory rate | 16 /min | 9279-1 | S |
| 2003-02-27 | Body temperature | 36.7 Cel | 8310-5 | S |
| 2003-02-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 % | 59408-5 | S |
| 2003-03-27 | Body height | 188 cm | 8302-2 | S |
| 2003-03-27 | Body weight | 95 kg | 29463-7 | S |
| 2003-03-27 | Body mass index (BMI) [Ratio] | 26.9 kg/m2 | 39156-5 | S |
| 2003-03-27 | Systolic blood pressure | 142 mm[Hg] | 8480-6 | S |
| 2003-03-27 | Diastolic blood pressure | 78 mm[Hg] | 8462-4 | S |
| 2003-03-27 | Heart rate | 76 /min | 8867-4 | S |
| 2003-03-27 | Respiratory rate | 16 /min | 9279-1 | S |
| 2003-03-27 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2003-03-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 % | 59408-5 | S |
| 2003-05-29 | Body height | 188 cm | 8302-2 | S |
| 2003-05-29 | Body weight | 93.5 kg | 29463-7 | S |
| 2003-05-29 | Body mass index (BMI) [Ratio] | 26.5 kg/m2 | 39156-5 | S |
| 2003-05-29 | Systolic blood pressure | 136 mm[Hg] | 8480-6 | S |
| 2003-05-29 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 2003-05-29 | Heart rate | 74 /min | 8867-4 | S |
| 2003-05-29 | Respiratory rate | 16 /min | 9279-1 | S |
| 2003-05-29 | Body temperature | 36.7 Cel | 8310-5 | S |
| 2003-05-29 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 % | 59408-5 | S |
| 2003-08-14 | Body height | 188 cm | 8302-2 | S |
| 2003-08-14 | Body weight | 92.5 kg | 29463-7 | S |
| 2003-08-14 | Body mass index (BMI) [Ratio] | 26.2 kg/m2 | 39156-5 | S |
| 2003-08-14 | Systolic blood pressure | 134 mm[Hg] | 8480-6 | S |
| 2003-08-14 | Diastolic blood pressure | 74 mm[Hg] | 8462-4 | S |
| 2003-08-14 | Heart rate | 72 /min | 8867-4 | S |
| 2003-08-14 | Respiratory rate | 16 /min | 9279-1 | S |
| 2003-08-14 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2003-08-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 % | 59408-5 | S |
| 2003-04-24 | Body height | 188 cm | 8302-2 | S |
| 2003-04-24 | Body weight | 94.2 kg | 29463-7 | S |
| 2003-04-24 | Body mass index (BMI) [Ratio] | 26.7 kg/m2 | 39156-5 | S |
| 2003-04-24 | Systolic blood pressure | 138 mm[Hg] | 8480-6 | S |
| 2003-04-24 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 2003-04-24 | Heart rate | 75 /min | 8867-4 | S |
| 2003-04-24 | Respiratory rate | 16 /min | 9279-1 | S |
| 2003-04-24 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2003-04-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 % | 59408-5 | S |
Social, functional, and mental status
Social history
- S No tobacco use; no current alcohol use
- S Past amphetamine and barbiturate use in his twenties and thirties, with residential treatment in his early fifties; no use since. Avoid prescribing controlled stimulants and sedatives, and review any opioid or benzodiazepine with him first
- S Occupation: recording artist and songwriter, now recording at home rather than touring
- S Supports: a family member who comes to visits and fills his pill organizer, and his church community
Functional status
- S Orthostatic vital signs at intake: 146/80 seated and 112/68 after three minutes standing, heart rate 78 to 82; lightheaded on standing and two falls in six months
- S Walks with a cane; reduced vibration and monofilament sensation to the ankles in both feet; independent in basic activities of daily living
- S Low vision from advanced glaucoma: tunnel vision in both eyes and difficulty in dim light; no longer drives
Mental status
- S Alert, oriented, and wry; speaks frankly about his past substance use and his faith
- S Mood euthymic; PHQ-2 negative; Mini-Cog normal
Allergies and medications
Allergies
- S No known allergy
Medications
- S Metformin 500 mg oral tablet, one tablet by mouth twice daily with meals
- S Metformin 1000 mg oral tablet, one tablet by mouth twice daily with meals
- S Sitagliptin 100 mg oral tablet, one tablet by mouth daily
- S Atorvastatin 40 mg oral tablet, one tablet by mouth daily
- S Latanoprost 0.005% ophthalmic solution, one drop in each eye at bedtime
- S Dorzolamide 2% ophthalmic solution, one drop in each eye twice daily
- S Midodrine 2.5 mg oral tablet, one tablet by mouth three times daily, last dose by 6 PM
- S Midodrine 5 mg oral tablet, one tablet by mouth three times daily, last dose by 6 PM
Procedures and immunizations
Procedures
- S Comprehensive diabetic foot examination with 10-g monofilament and vibration testing
- S Optical coherence tomography of the optic nerve and retinal nerve fiber layer, both eyes
- S Dilated eye examination and Humphrey 24-2 visual field testing, both eyes
- S Optical coherence tomography of the optic nerve and retinal nerve fiber layer, both eyes
- S Humphrey 24-2 visual field testing, both eyes
Immunizations
- S 2002-10-20: High-dose influenza vaccine, 2002-2003 season
- S 2003-02-27: Pneumococcal conjugate vaccine PCV20
- S 2003-05-29: Recombinant zoster vaccine, dose 1
Past medical history
True biography with historical dates; not part of the synthetic care timeline.
- D 1957: Amphetamine use beginning in 1957, with barbiturates in the 1960s; addiction lasting about a decade (CLM-0004)
- D 1983: Hospitalized in 1983 with internal bleeding, followed by treatment at the Betty Ford Clinic (CLM-0005)
- D October 1997: Diagnosed with Shy-Drager syndrome in October 1997; he said in 2000 that it was a misdiagnosis, and autonomic neuropathy was later identified (CLM-0006, CLM-0007)
- D February 2001: Pneumonia treated at Baptist Hospital in Nashville in February 2001, one of several pneumonia admissions (CLM-0008)
Family history
- D brother: Older brother Jack died in a sawmill accident in 1944
Care-plan goals
| Goal | Target date | Status | Outcome |
|---|---|---|---|
| Reach an HbA1c below 7.5% without hypoglycemia by the six-month review | 2003-08-14 | completed | HbA1c fell from 8.6% to 7.3% with no hypoglycemia |
| No falls and a standing systolic pressure of 100 mm Hg or more by the six-month review | 2003-08-14 | completed | No falls since the second visit; 134/74 seated and 120/70 standing on midodrine |
| Lower intraocular pressure to 16 mm Hg or less in each eye by the three-month review | 2003-05-29 | completed | Pressure 15 mm Hg right and 16 mm Hg left at three months |
| LDL cholesterol below 70 mg/dL by the six-month review | 2003-08-14 | active | LDL 74 mg/dL at three months; recheck at the annual visit |
Interventions
| Intervention | Status | Guideline |
|---|---|---|
| Increase metformin to 1000 mg twice daily and set an individualized HbA1c goal below 7.5%; avoid insulin and sulfonylureas while autonomic neuropathy may blunt warning symptoms of hypoglycemia | completed | GL-ADA-2025, GL-CMID-2026 |
| Endocrinology consultation to confirm diabetic autonomic neuropathy as the cause of orthostatic hypotension, reconsider the earlier Shy-Drager label, and choose add-on glucose-lowering therapy | completed | GL-ADA-2025 |
| Treat neurogenic orthostatic hypotension: stand up in stages, raise the head of the bed, use waist-high compression, drink 2 liters of fluid a day, then midodrine with the last dose at least four hours before bed; check supine blood pressure at each visit | completed | GL-ADA-2025 |
| Check HbA1c every three months until at goal, a basic metabolic panel, UACR, and lipids each year, lipids 4 to 12 weeks after starting a statin, and vitamin B12 periodically on metformin | completed | GL-CMID-2026, GL-ADA-2025 |
| Examine the feet at every visit because of sensory loss; daily self-inspection and protective footwear | completed | GL-ADA-2025, GL-CMID-2026 |
| Coordinate glaucoma care with the eye clinic: add dorzolamide to latanoprost, check pressure at each visit, and repeat OCT and visual fields every six months; avoid timolol and brimonidine because of bradycardia, bronchospasm, and low blood pressure | completed | GL-AAO-POAG-2025, GL-CMID-2026 |
| Annual dilated eye examination for diabetic retinopathy; low-vision rehabilitation and home lighting review | completed | GL-ADA-2025, GL-AAO-POAG-2025 |
| Start atorvastatin 40 mg; give PCV20 and recombinant zoster vaccines | completed | GL-ADA-2025 |
Planned encounters
- 2003-02-27 — Primary care new-patient visit for diabetes, lightheadedness on standing, and glaucoma follow-up (ENC-001)
- 2003-03-27 — Endocrinology consultation for diabetes and autonomic neuropathy (ENC-002)
- 2003-04-24 — Subsequent annual wellness visit (ENC-005)
- 2003-05-29 — Three-month diabetes, blood pressure, and eye pressure review (ENC-003)
- 2003-08-14 — Six-month diabetes review with glaucoma imaging (ENC-004)
Supporting documents
- History and physical
- Progress note 01
- Progress note 02 — Focused Visit (Follow-up)
- Progress note 03 — Annual Wellness Visit, Subsequent
- Progress note 04 — Focused Visit (Follow-up)
- Progress note 05 — Focused Visit (Care-plan review)
- Endocrinology referral
- Endocrinology consultation
- Patient care plan
- Teaching note
- Provenance CSV
C-CDA note documents
Each link opens a readable copy; the XML beside it is the exchange file.
- History and physical (XML)
- Progress note 01 (XML)
- Progress note 02 — Focused Visit (Follow-up) (XML)
- Progress note 03 — Annual Wellness Visit, Subsequent (XML)
- Progress note 04 — Focused Visit (Follow-up) (XML)
- Progress note 05 — Focused Visit (Care-plan review) (XML)
- Endocrinology referral (XML)
- Endocrinology consultation (XML)
Sources
| ID | Source | Publisher | Type |
|---|---|---|---|
| SRC-0001 | Johnny Cash (1932-2003) | CALS Encyclopedia of Arkansas | scholarly |
| SRC-0002 | Johnny Cash Battles Recurring Pneumonia | ABC News | other |
| SRC-0003 | Larry King Live: Interview With Johnny Cash (transcript) | CNN | primary |
| SRC-0004 | Johnny Cash Dies | Pollstar | other |
| SRC-0005 | HISTMED Master Roster v3 | The Human Record project | other |
Review status
| Review | Status | Notes |
|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | Awaiting clinician review. |
| provenance review | not_started | Recent-death rule: only facts Cash, his manager, or published reference works made public are used. Encyclopedia of Arkansas, ABC News, CNN transcript, and Pollstar logged. |
| safe messaging review | not_started | Historical substance use is recorded as history, marked sensitive, and is not a modern diagnosis. Death recorded without graphic detail. |
Comments and corrections
Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.
Comments appear on the online version of this page.